Kraft Heinz will be pulling certain artificial dyes from its U.S. products starting in 2027 and will no longer roll out new ...

The FDA announced a new fast-track approval program for domestic drug developers for projects that are national priorities.

Eli Lilly agreed to acquire Verve Therapeutics for about $1 billion upfront, adding a potential treatment for cardiovascular ...

Vita Warehouse Corp. voluntarily issued the recall on Thursday, June 12, for one lot of B12 vitamin gummies under brand names ...

Biotech stock Mirum Pharmaceuticals has rocketed 236% since its IPO in 2019. Shares are near a buy point after earnings.

Kraft Heinz announced on Tuesday that it will remove all FD&C artificial dyes from its U.S. portfolio by the end of 2027 amid pressure from the Trump administration to phase out artificial colors from ...

The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions ...

Limiting pharma ads would be a major win for Health and Human Services Secretary Robert F. Kennedy Jr. He’s long wanted to ...

The company's application included a submitted dose of 0.04 millimole gadolinium per kilogram of body weight. If approved, gadoquatrane would become the lowest dose macrocyclic gadolinium-based ...

Food giant Kraft Heinz will remove all artificial colors from its brands as synthetic food dyes face renewed scrutiny from ...